ArticleJournal for immunotherapy of cancer2025

RANKL blockade inhibits cancer growth through reversing the tolerogenic profile of tumor-infiltrating (plasmacytoid) dendritic cells.

Charlotte Pilard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.